ClinicalTrials.gg
RecruitingNCT05316623Updated Dec 21, 2023

Using Peripheral Neurostimulation to Improve Work Rehabilitation

An interventional study of TENS in Chronic Pain, sponsored by Université de Sherbrooke. Recruiting at 1 site in Canada. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2023-12-21.

Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2023; still recruiting 3 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Chronic Pain by Université de Sherbrooke — 8 open to participants now, 9 under way, none of them phase 3. Chronic Pain · Université de Sherbrooke.

Planned enrollment
8th of 11
24 · median 32
Started
2023
with 1 other
No phase
10 of 15
7 open now
Registered
10th of 15
by date

Among the 15 studies in Chronic Pain by Université de Sherbrooke, this one is the 8th largest by planned enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2023, is one of 10 with no phase, and was the 10th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

8 of the 15 studies in Chronic Pain by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 55 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Chronic Pain by Université de Sherbrooke, or all of them as a file.
02

Study summary

Physical exercise plays a central role in work rehabilitation. However, the presence of pain (particularly common in older adults and aging workers) can lead to a fear of movement (kinesiophobia) and hinder rehabilitation. Access to rehabilitation care is also a barrier for many older adults, which could be circumvented through telerehabilitation. The objective of this pilot study is to document the feasibility and explore the effect of a telerehabilitation intervention combining therapeutic exercises and real TENS (experimental group) or placebo TENS (control group) in individuals aged 55 and over who have stopped working (triple-blind randomized controlled study). To do so, various feasibility indicators (e.g., recruitment rate, adherence) and clinical measures (e.g., kinesiophobia, pain during exercise) will be documented before and after the intervention. Together, these measures will help assess the appropriateness of conducting a large-scale study aimed at potentiating work rehabilitation in older populations.

Read the detailed description

Problem and hypotheses:

In 2019, the proportion of Canadians aged 55 and over who were employed was 35.9%, the highest rate recorded to date since 1976. Despite their willingness to remain employed, seniors are more prone to work disability and early retirement. Older workers with disabilities are particularly vulnerable to job retention. In Quebec, the average length of absence following a work-related injury is 134 days for workers aged 55 and over, while it is less than 50 days for those aged 15 to 24. This difference can be explained in part by the presence of persistent pain that disproportionately affects older individuals and can significantly impede rehabilitation to work. The indirect costs associated with unemployment and absenteeism of people living with chronic pain were estimated to be $22.5 billion in Canada in 2019. A recent review conducted and published by our team found that strategies to reduce pain are one of the most important elements to consider in enabling workers to remain in the workplace after an episode of musculoskeletal disorder.

Exercise plays a central role in chronic pain management and work rehabilitation. However, pain can be a major barrier to physical activity. Therefore, finding ways to reduce pain during and after exercise is essential to facilitate rehabilitation. Peripheral neurostimulation (TENS) - an electrotherapeutic modality that uses an electrical current to depolarize peripheral nerve fibers with electrodes applied directly to the skin - is effective in temporarily relieving pain. It represents an interesting avenue for increasing exercise tolerance associated with exercise in the pain subject. To date, 3 studies have investigated the use of TENS during exercise, all showing positive results. None, however, have yet investigated this strategy (TENS + exercise) in aging workers living with persistent pain.

We postulate that telerehabilitation treatments (therapeutic exercises) provided concurrently with actual TENS will be more effective in reducing the biopsychological impacts of pain than the same rehabilitation treatments paired with placebo TENS. Thus, our hypothesis is that the experimental treatment will cause participants to enter a "virtuous circle": the TENS will allow for a punctual reduction of pain and kinesiophobia, which will encourage the realization/resumption of activity and lead to sustained benefits (e.g., physical function, pain, mood).

Objectives:

The primary objective of this pilot study is to explore the feasibility and acceptability of using real TENS, compared to placebo TENS, as a complementary treatment to a telerehabilitation exercise program, in workers who are off work.

The secondary objective is to compare the effect of the two types of intervention (real TENS + exercises vs. placebo TENS + exercises) on clinical outcomes (e.g. pain intensity, functioning in vocational rehabilitation, etc.).

Methods and analysis:

Design:

This project consists of a randomized controlled trial following a quadruple blind design.

Participants:

The target population is aging workers who are off work due to a musculoskeletal injury.

Sampling and recruitment procedures:

Participants will be recruited at the ISO-SANTÉ and Physio-Atlas clinics in Sherbrooke, which specialize in work rehabilitation (volunteer, non-probability sampling). The recruitment of individuals will be done through posters and with the help of clinicians who will be invited to talk to patients about the project.

Conduct of the study:

The purpose of this study is to recruit 24 participants who will take part in an exercise program spread over 3 weeks, with 3 sessions per week. The duration of each session is 30 minutes. The exercise program will be determined by the research team, in collaboration with clinic health professionals, and the exercises will be delivered via the TeraPlus telerehabilitation platform. The TENS (real or simulated) will be worn by participants throughout their telerehabilitation exercises, under the supervision of the student researcher.

03

Conditions studied

  • Chronic Pain

Browse trials for

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 55 years of age or older
  • Being off work completely due to a musculoskeletal injury
  • Starting a physical rehabilitation program
  • Being in employment
  • Experiencing pain of mild intensity (score of 1-3 points on a numerical scale of 0-10 points) to moderate intensity (score of 4-6 points) during movements/exercises
  • Being comfortable enough with technology to participate in video conferences, respond to emails or text messages
  • Having stable medication and lifestyle habits
  • Speaking French

Exclusion criteria

Exclusion Criteria:

  • Having a cognitive deficiency
  • Wearing a cardiac defibrillator or pacemaker
  • Being diagnosed with cancer
  • Having already experimented with TENS
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Sham comparator
    Control group

    Simulated TENS and personalized exercise program in telerehabilitation (3 sessions/week over 3 weeks) n = 12

    Device: TENS

  • Experimental
    Intervention group

    Real TENS and personalized exercise program in telerehabilitation (3 sessions/week over 3 weeks) n = 12

    Device: TENS

Interventions

  • DeviceTENS

    TENS (strong and comfortable intensity) applied during exercises in a telerehabilitation setting.

    Also known as: Transcutaneous electrical nerve stimulation, Peripheral neurostimulation

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    The number of participants randomized divided by the number of participants screened.

    Time frame: 4 months

  2. Exclusion rate

    The number of ineligible participants divided by the number of participants screened.

    Time frame: 4 months

  3. Refusal rate

    The number of participants who refused to participate in the trial divided by the number of participants screened.

    Time frame: 4 months

  4. Adherence rate

    The number of people who finished intervention divided by the number of participants randomized.

    Time frame: 3 weeks

  5. Attrition rate

    The number of people who did not finish intervention divided by the number of participants randomized.

    Time frame: 3 weeks

  6. Kinesiophobia

    excessive, irrational, and debilitating fear of physical movement and activity resulting from a feeling of vulnerability due to painful injury or reinjury - Measured with the Tampa scale of kinesiophobia

    Time frame: 3 weeks

Secondary outcomes

  1. Severity of pain and impact of pain on physical function

    Measured with the Brief Pain Inventory (BPI)

    Time frame: 3 weeks

  2. Pain intensity

    Measured with a visual analog scale (VAS). Scale from 0 to 100, where 0 indicates no pain and 100 indicates worst pain imaginable

    Time frame: 3 weeks

  3. Psychosocial component and impact of pain on the emotional sphere

    Measured with Beck's depression inventory. Contains 21 items with a 4-point likert scale. The minimum possible score is 0 and the maximum possible score is 63. The higher the score, the more important the psychosocial component is for the individual.

    Time frame: 3 weeks

  4. Qualitative component of pain

    McGill Pain Questionnaire (MPQ). The MPQ is composed of 20 questions and scores range from 0 (no pain) to 78 (severe pain).

    Time frame: Intervention period (before first and after last sessions)

  5. Pain catastrophizing

    Measured with the Pain Catastrophizing Scale. It consists of 13 thoughts or emotions related to a painful experience. Each thought is scored on 5 points from 0 to 4. The total score is 52 points. If the score is between 20 and 29, the risk of pain chronicization is moderate. If the score is between 29 and 52, the risk is high. The higher the score, the higher the risk.

    Time frame: 3 weeks

  6. Disability in work Rehabilitation

    Measured with the Work Rehabilitation Questionnaire (WORQ). The WORQ is used to better understand the extent of problems in functioning that people may have due to their health condition(s) and who are undergoing work or vocational rehabilitation. In the main section, responders rate the extent of their problem in the past week on a scale from 0 (no problem) to 10 (complete problem / not possible).

    Time frame: 3 weeks

  7. Overall treatment satisfaction

    Measured with The self-report measure Patient Global Impression of Change (PGIC). PGIC is a 7 point scale depicting a patient's rating of overall improvement. Patients rate their change as "very much improved," "much improved," "minimally improved," "no change," "minimally worse," "much worse," or "very much worse."

    Time frame: 3 weeks

  8. Quality of movement

    Measuring the posture of the participants during the execution of a squat (sagittal view on camera). Based on the Back Squat Assessment.

    Time frame: 3 weeks

  9. Quality of movement

    Measuring the posture of the participants during the execution of a squat (sagittal view on camera). Based on the squat portion of the New Basic Functional Assessment Protocol.

    Time frame: 3 weeks

07

Study locations

1 of 1 sites recruiting
  • Centre de recherche sur le vieillissement (CdRV)
    Sherbrooke, Quebec J1H 4C4, Canada
    Recruiting
    • Guillaume Leonard, Ph.D., pht. · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2023 (actual). Primary completion is estimated for Aug 2024, 12 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 12 months is below that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 15, 2022
First posted
Apr 7, 2022
StartActual
Aug 8, 2023
Primary completionEst.
Aug 2024
CompletionEst.
Dec 2024
Last update
Dec 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05316623
Collaborators
Réseau Provincial De Recherche En Adaptation-Réadaptation (REPAR), Réseau québécois de recherche sur le vieillissement (RQRV)
Responsible party
Guillaume Léonard (Professor, Université de Sherbrooke) — Principal investigator
First posted
Apr 7, 2022
Start date
Aug 8, 2023
Primary completion
Aug 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Dec 21, 2023

Study contacts

Marie-Philippe Harvey, M. Sc.
Contact
Marie.Philippe.Harvey@USherbrooke.ca
819-780-2220 ext. 45156
Guillaume Léonard, PhD
Contact
Guillaume.Leonard2@Usherbrooke.ca
819-821-8000 ext. 72933
Guillaume Léonard, PhD
principal investigator · Université de Sherbrooke

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion